rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Clene Inc.

CLNN · Nasdaq

Health CareBiotechnologyNot moving yet

CLNN stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 23 weeks. It is 42.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 23
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$433K
Insider sales, 12 months
$9.6M
Officials’ trades on record
0
Institutions holding
32 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months62
Buyers · sellers1 · 1
WhoDidSharesTraded
Chidozie Ugwumba10% ownersold73,296at $6.2012 May 2026filed 13 May 2026
Chidozie Ugwumba10% ownersold22,177at $6.7511 May 2026filed 13 May 2026
Chidozie Ugwumba10% ownersold72,884at $6.804 May 2026filed 5 May 2026
Chidozie Ugwumba10% ownersold5,795at $6.011 May 2026filed 5 May 2026
Chidozie Ugwumba10% ownersold5,736at $6.0830 Apr 2026filed 30 Apr 2026
Chidozie Ugwumba10% ownersold12,170at $5.6329 Apr 2026filed 30 Apr 2026
Chidozie Ugwumba10% ownersold1,591at $5.9028 Apr 2026filed 30 Apr 2026
Chidozie Ugwumba10% ownersold61,345at $6.1421 Apr 2026filed 22 Apr 2026
Chidozie Ugwumba10% ownersold4,318at $6.1220 Apr 2026filed 22 Apr 2026
Chidozie Ugwumba10% ownersold25,040at $6.4317 Apr 2026filed 17 Apr 2026
Chidozie Ugwumba10% ownersold7,748at $6.4016 Apr 2026filed 17 Apr 2026
Chidozie Ugwumba10% ownersold6,374at $6.4815 Apr 2026filed 17 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders32+3 on the quarter
New · exited6 · 3
Reported value$19.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Empery Asset Management, LPnew · filed 11 Aug 2026916,532$5.6M+916,532
SCOGGIN MANAGEMENT LPadded · filed 14 Aug 2026600,000$3.7M+300,000+100.0%
Boxer Capital Management, LLCunchanged · filed 14 Aug 2026477,515$2.9M00.0%
Ensign Peak Advisors, Incadded · filed 14 Aug 2026348,062$2.1M+90,190+35.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026333,706$2.1M+25,476+8.3%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026102,215$630K+6,341+6.6%
BlackRock, Inc.added · filed 7 Aug 202661,559$379K+27,760+82.1%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202657,765$356K+14,050+32.1%
Lunt Capital Management, Inc.unchanged · filed 30 Jul 202652,260$322K00.0%
PARSONS CAPITAL MANAGEMENT INCunchanged · filed 24 Jul 202637,243$229K00.0%
30 Sep 2024 – 30 Jun 2026
192632Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Alison Mosca Company insiderDirector, 10% owner · last 16 Sep 20264 · 0
David J. Matlin Company insiderDirector · last 16 Sep 202629 · 0
Robert Dee Etherington Company insiderPresident & CEO · last 16 Sep 20262 · 1
Arjun J.J. Desai Company insiderDirector · last 13 Aug 20260 · 0
Jonathon Gay Company insiderDirector · last 13 Aug 20263 · 0
Matthew Kiernan Company insiderDirector · last 13 Aug 20260 · 0
Reed N. Wilcox Company insiderDirector · last 13 Aug 20260 · 0
Shalom Jacobovitz Company insiderDirector · last 13 Aug 20260 · 0
Vallerie McLaughlin Company insiderDirector · last 13 Aug 20260 · 0
Chidozie Ugwumba Company insider10% owner · last 17 Jul 20262 · 62
Mark Mortenson Company insiderChief Science Officer · last 11 Jun 20261 · 1
Morgan R. Brown Company insiderChief Financial Officer · last 11 Jun 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202578.5%
Interest coverFY 2025 · to 31 Dec 2025-8.61×
Share count trendFY 2025 · to 13 Mar 20268.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$5.2M
Free cash flowFY 2025 · to 31 Dec 2025−$18.6M

Analyst forecasts

No analyst forecasts yet.